… Volume 12 / Issue 4 / April 2016 n Journal of Oncology Practice Copyright © 2016 by
American Society of Clinical Oncology … Nofisat Ismaila … Volume 12 / Issue 4 / April 2016 …

Context: ERBB2 (erb-b2 receptor tyrosine kinase 2 or HER2) is currently the only biomarker
established for selection of a specific therapy for patients with advanced gastroesophageal …

PURPOSE To provide evidence-based recommendations to practicing clinicians on
management of patients with stage III non–small-cell lung cancer (NSCLC). METHODS An Expert …

PURPOSE To update recommendations on appropriate use of breast cancer biomarker
assay results to guide adjuvant endocrine and chemotherapy decisions in early-stage breast …

PURPOSE To provide evidence-based recommendations for practicing physicians and other
healthcare providers on the management of salivary gland malignancy. METHODS ASCO …

PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to
practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy …

… MINDACT study, the number of patients with this tumor subtype was small (n = 640 [9.6%]).
The majority of women with this subtype (n = 566 [88%]) were classified as high clinical and …

PURPOSE: The American College of Chest Physicians (ACCP) produced an evidence-based
guideline on treatment of patients with small-cell lung cancer (SCLC). Because of the …

… The current AJCC/UICC staging classification remains difficult to apply to clinical staging
with respect to both T and N components and thus may be imprecise in predicting prognosis. …

… pain associated with head and neck cancer76 (N 5 40) and the second evaluated hatha
yoga for musculoskeletal pain among patients with breast cancer (N 5 42).Both trials had small …